Ryan Schoenfeld is an expert in medicinal chemistry with extensive experience working across functional boundaries in data science and disease biology. Over the course of 15+ years as a scientific leader in the pharmaceutical industry and nonprofit sectors, Ryan has played a major role in the discovery and advancement of four novel small molecule therapeutics to human clinical trials. He is the author of numerous peer-reviewed scientific publications and is a named inventor on over 25 patents.
Ryan was Senior Director of Data Sciences at Janssen Pharmaceutical Companies of Johnson & Johnson, where he built and led a large global team of data scientists who delivered high impact machine learning and AI-based solutions for a wide range of problems across all therapeutic areas, including oncology. Prior to his time at J&J, Ryan was a Scientific Director at the CHDI Foundation, where he pursued therapeutics for Huntington’s disease, directing teams of global collaborators in medicinal chemistry, chemical biology, structural biology, imaging biomarkers, and stem cell research. Earlier in his career, Ryan worked for Roche Pharmaceuticals where he led medicinal chemistry and chemical biology projects across several different therapeutic areas, coordinated global research informatics initiatives, and oversaw all North America-based discovery chemistry and biology outsourcing with contract research organizations.
Ryan received a PhD in Chemistry from Cornell University studying organic synthesis with Professor Bruce Ganem, and a BS in Chemistry from California Polytechnic State University. Ryan joined The Mark Foundation in January 2018.